Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:18 AM
Study NCT ID:
NCT03188120
Status:
COMPLETED
Last Update Posted:
2019-11-27
First Post:
2017-06-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Specific Use-Result of Spiriva Respimat® in Asthmatics
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-13
First Submit QC Date:
None
Study First Post Date:
2017-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-11-08
Results First Submit QC Date:
None
Results First Post Date:
2019-11-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-08
Last Update Post Date:
2019-11-27
Last Update Post Date Type:
ACTUAL